This company is no longer active
The company may no longer be operating, as it may be out of business. Find out why through their latest events.
Second Sight Medical Products Balance Sheet Health
Financial Health criteria checks 6/6
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$56.38m |
| Equity | US$63.06m |
| Total liabilities | US$2.59m |
| Total assets | US$65.65m |
Recent financial health updates
Recent updates
Second Sight, Nano Precision complete merger, renaming as Vivani Medical
Aug 30Second Sight Medical sheds ~17% after reverse stock split
Aug 19Second Sight stock rises as shareholders approve merger, name change, reverse stock split
Jul 29Second Sight stock rises ~10% on $1.1M funding from NIH for artificial vision implant trial
Jul 18Revisiting Second Sight Medical Products: The EV Is Negative And Being Short No Longer Looks Appealing
Mar 22Second Sight Medical rises defying legal battle; regains NASDAQ compliance
Jun 04Financial Position Analysis
Short Term Liabilities: EYES's short term assets ($57.4M) exceed its short term liabilities ($2.6M).
Long Term Liabilities: EYES has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: EYES is debt free.
Reducing Debt: EYES had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: EYES has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: EYES has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 13.1% each year